River Stone Biotech ApS: Financial statements 2020
CVR: 39126729
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
River Stone Biotech ApS (CVR 39126729) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,476,810 and a net result of DKK -16,064,190 compared with DKK -14,329,089 the year before. That is an increase of 258% compared with the year before. Equity in the 2020 report amounted to DKK 8,948,346. The solvency ratio was 68.3%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 2,476,810
- Profit/Loss
- DKK -16,064,190
- Equity
- DKK 8,948,346
- Total Assets
- DKK 13,105,561
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.5 mio. | -16.1 mio. | 8.9 mio. | 15 |
| 2019 | - | 692 t. | -14.3 mio. | 10.1 mio. | 13 |
| 2018 | - | - | -11.1 mio. | -11.1 mio. | 11 |
Official annual report
How creditworthy is River Stone Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
River Stone Biotech ApS has published its annual report for 2019. Gross profit came to DKK 691,841, and the net result was DKK -14,329,089.
About River Stone Biotech ApS
River Stone Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jørgen Hansen. The board consists of Jørgen Hansen and Paul D. Goldenheim. The company is owned by River Stone Biotech Inc.. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK 1,169,131 and a net result of DKK -31,204,765 compared with DKK -44,572,973 the year before. Equity in the 2025 report amounted to DKK 7,827,761.